Testing effectiveness (Phase 2)WithdrawnNCT06881823
What this trial is testing
Study to Assess [177Lu]Lu-PSMA-R2 (AAA602) and [225Ac]Ac-PSMA-R2 (AAA802) in Participants With PSMA-positive HRLPC
Who this might be right for
Prostate Cancer
Novartis Pharmaceuticals